ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1844

Mesenchymal Stem Cells Ameliorate the Deficiencies in Immunomodulatory and Phagocytic Capacities of Lupus Macrophages

Wei Deng1, Weiwei Chen1, Zhuoya Zhang2, Saisai Huang1, Wei Kong1, Xuebing Feng1 and Lingyun Sun1, 1Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China, 2The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Macrophage, Mesenchymal stem cells and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Evidence has accumulated that umbilical cord (UC)-derived mesenchymal stem cells (MSCs) show therapeutic effects on systemic lupus erythematosus (SLE). Deficiency in SLE macrophages exhibits excessive activation and inefficient clearance of self nuclear antigens. In this study, we aim to investigate whether UC-MSCs could increase the immunomodulatory function and phagocytic activity of lupus macrophages.

Methods:  Blood samples were collected from 9 SLE patients, who fulfilled the SLE diagnostic criteria of American College of Rheumatology in 1999. All patients’ Systemic Lupus Erythematosus Disease Activity Indexes (SLEDAI) were above 8. CD14+ monocytes were isolated from peripheral blood of healthy donors (HCs) and SLE patients. We cultured human monocytes for 7 days with macrophage colony-stimulating factor (M-CSF) to generate macrophages, and then co-cultured them for 2 more days with/without UC-MSCs in transwell culture systems. CD4+ T cells isolated from HCs were co-cultured with/without prepared macrophages. After 4 days, the proliferation levels of T cells were detected by flow cytometry. To determine the phagocytic activity of macrophages, apoptotic neutrophils were added into the cultures for 2 hours. The uptake of apoptotic cells were determined by flow cytometry.

Results: Compared with HC macrophages, the immunomodulatory function of SLE macrophages was impaired. SLE macrophages were incapable of suppressing the proliferation of CD4+ T cells effectively. The phagocytic activity of SLE macrophages was also deficient in engulfment of apoptotic cells. Next, we determined the capacities of immunomodulatory and phagocytosis of SLE macrophages co-cultured with UC-MSCs in a transwell system. Flow cytometric analysis showed that SLE macrophages co-cultured with UC-MSCs significantly increased the abilities to suppress the CD4+ T cells proliferation and phagocytic activities to engulf apoptotic neutrophils compared with macrophages cultured alone.

Conclusion: Our results indicate that UC-MSCs promoted the immunomodulatory function and phagocytic activity of macrophages in SLE, providing a novel mechanism for MSC-therapeutic function for SLE.


Disclosure: W. Deng, None; W. Chen, None; Z. Zhang, None; S. Huang, None; W. Kong, None; X. Feng, None; L. Sun, None.

To cite this abstract in AMA style:

Deng W, Chen W, Zhang Z, Huang S, Kong W, Feng X, Sun L. Mesenchymal Stem Cells Ameliorate the Deficiencies in Immunomodulatory and Phagocytic Capacities of Lupus Macrophages [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/mesenchymal-stem-cells-ameliorate-the-deficiencies-in-immunomodulatory-and-phagocytic-capacities-of-lupus-macrophages/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mesenchymal-stem-cells-ameliorate-the-deficiencies-in-immunomodulatory-and-phagocytic-capacities-of-lupus-macrophages/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology